Automate Your Wheel Strategy on GMED
With Tiblio's Option Bot, you can configure your own wheel strategy including GMED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GMED
- Rev/Share 20.593
- Book/Share 32.7045
- PB 2.662
- Debt/Equity 0.0271
- CurrentRatio 4.1299
- ROIC 0.0735
- MktCap 11651450659.0
- FreeCF/Share 4.3093
- PFCF 20.1024
- PE 27.6317
- Debt/Assets 0.0234
- DivYield 0
- ROE 0.0999
- Rating A
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | GMED | BofA Securities | Neutral | Buy | -- | $91 | Nov. 7, 2025 |
| Upgrade | GMED | Truist | Hold | Buy | -- | $93 | Nov. 7, 2025 |
| Resumed | GMED | Stifel | -- | Hold | -- | $64 | Oct. 28, 2025 |
| Downgrade | GMED | BTIG Research | Buy | Neutral | -- | -- | May 27, 2025 |
| Upgrade | GMED | BofA Securities | Underperform | Neutral | -- | $97 | Jan. 10, 2025 |
News
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.60 per share a year ago.
Read More
Globus Medical: Q4 Revenue Tops Forecast
Published: February 20, 2025 by: The Motley Fool
Sentiment: Positive
Medical technologies specialist Globus Medical (GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million.
Read More
About Globus Medical, Inc. (GMED)
- IPO Date 2012-08-03
- Website https://www.globusmedical.com
- Industry Medical - Devices
- CEO Keith W. Pfeil
- Employees 5300